Nasty shock after an anti-emetic

Nephrology Dialysis Transplantation

Volumn 16, Issue 5, 2001, Pages 1069-1072

  Maxwell, P H ^a   Buckley, C ^a   Gleadle, J M ^a   Mason, P D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIEMETIC AGENT; DIAMORPHINE; DOBUTAMINE; DOPAMINE; FUROSEMIDE; METOCLOPRAMIDE; NITRATE; OXYGEN;

AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SEPTICEMIA; SHOCK; VOMITING;

EID: 0035006166     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.5.1069     Document Type: Article

References (14)

1. Ross NS, Aron DC. Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med 1990; 323: 1401-5
2. Pauker SG, Kopelman RI. Interpreting hoofbeats: can Bayes help clear the haze? N Engl J Med 1992; 327: 1009-13
3. Lenders JW, Keiser HR, Goldstein DS, Willemsen JJ, Friberg P, Jacobs MC et al. Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med 1995; 123: 101-9
4. Abecassis M, McLoughlin MJ, Langer B, Kudlow JE. Serendipitous adrenal masses: prevalence, significance, and management. Am J Surg 1985; 149: 783-8
5. Hedeland H, Ostberg G, Hokfelt B. On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 1968; 184: 211-4
6. Sutton MG, Sheps SG, Lie JT. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc 1981; 56: 354-60
7. Gifford RJ, Kvale W, Maher F, Roth G, Priestley J. Clinical features, diagnosis and treatment of pheochromocytoma: a review of 76 cases. Mayo Clin Proc 1964; 39: 281-302
8. Neumann HP, Berger DP, Sigmund G, Blum U, Schmidt D, Parmer RJ et al. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med 1993; 329: 1531-8
9. Eng C. Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease. N Engl J Med 1996; 335: 943-51.
10. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-5
11. Plouin PF, Menard J, Corvol P. Hypertensive crisis in patient with phaeochromocytoma given metoclopramide (letter). Lancet 1976; 2: 1357-8
12. Agabiti-Rosei E, Alicandria CL, Corea L. Hypertensive crisis in patients with phaeochromocytoma given metoclopramide (letter). Lancet 1977; 1: 600
13. Lyon RA, Titeler M, Bigornia L, Schneider AS. D2 dopamine receptors on bovine chromaffin cell membranes: identification and characterization by [3H]N-methylspiperone binding. J Neurochem 1987; 48: 631-5.
14. Pupilli C, Lanzillotti R, Fiorelli G, Selli C, Gomez RA, Carey RM et al. Dopamine D2 receptor gene expression and binding sites in adrenal medulla and pheochromocytoma (published erratum appears in J Clin Endocrinol Metab 1994 Oct; 79: 1165). J Clin Endocrinol Metab 1994; 79: 56-61.